[Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms]. 2009

Diego de Alcalá Martínez-Gómez, and Cristóbal Ramírez-Almagro, and Alvaro Campillo-Soto, and Germán Morales-Cuenca, and Jorge Pagán-Ortiz, and José Luis Aguayo-Albasini
Servicio de Cirugía General y Digestiva, Hospital General Universitario José María Morales Meseguer, Murcia, España.

BACKGROUND Foot infections are a common reason for hospitalization and a cause of complications in patients with diabetes. The aim of this study was to determine the prevalence of microorganisms found on culture in complicated diabetic foot infections in hospitalized patients, and the sensitivity of the causative microorganisms to antimicrobial agents. METHODS Between December 2001 and December 2005 in our department, 84 samples in 62 diabetic patients with moderate/severe infection were collected for microbiological study. RESULTS At least one microorganism was isolated in 88% of samples. The most frequently isolated germ group was gram-positive bacteria (55% of the samples), with Staphylococcus aureus (33%) in the first position, followed by Pseudomonas aeruginosa (12%), Enterococcus spp. (9%), and Escherichia coli (8%). Culture for anaerobic microorganisms was only performed in half the samples; 25% were positive, and Peptostreptococcus spp. predominated. Among the multiresistant microorganisms, methicillin-resistant staphylococci aureus (MRSA) were the most common, accounting for 38% of the isolated strains of S. aureus, ie, 12% of all samples. As to the gram-negative microorganisms, nearly 30% of E. coli strains were resistant to amoxicillin/clavulanic acid and ciprofloxacin. CONCLUSIONS Most of the cultures in our study were monomicrobial, with S. aureus being the most prevalent microorganism, followed by enterobacteria and P. aeruginosa. The main resistant microorganism in diabetic foot infections requiring hospitalization was methicillin-resistant golden staphylococcus, which was found in 12% of the series.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004747 Entamoeba A genus of ameboid protozoa characterized by the presence of beaded chromatin on the inner surface of the nuclear membrane. Its organisms are parasitic in invertebrates and vertebrates, including humans. Entamoebas
D004749 Entamoebiasis Infection with amoebae of the genus ENTAMOEBA. Infection with E. histolytica causes DYSENTERY, AMEBIC and LIVER ABSCESS, AMEBIC. Entamoeba Infections,Entamoeba histolytica Infection,Entamoeba Infection,Entamoeba histolytica Infections,Entamoebiases,Infection, Entamoeba,Infection, Entamoeba histolytica,Infections, Entamoeba,Infections, Entamoeba histolytica
D005260 Female Females

Related Publications

Diego de Alcalá Martínez-Gómez, and Cristóbal Ramírez-Almagro, and Alvaro Campillo-Soto, and Germán Morales-Cuenca, and Jorge Pagán-Ortiz, and José Luis Aguayo-Albasini
July 2016, Journal of diabetes and its complications,
Diego de Alcalá Martínez-Gómez, and Cristóbal Ramírez-Almagro, and Alvaro Campillo-Soto, and Germán Morales-Cuenca, and Jorge Pagán-Ortiz, and José Luis Aguayo-Albasini
January 2015, Journal of pathogens,
Diego de Alcalá Martínez-Gómez, and Cristóbal Ramírez-Almagro, and Alvaro Campillo-Soto, and Germán Morales-Cuenca, and Jorge Pagán-Ortiz, and José Luis Aguayo-Albasini
December 2001, Indian journal of medical sciences,
Diego de Alcalá Martínez-Gómez, and Cristóbal Ramírez-Almagro, and Alvaro Campillo-Soto, and Germán Morales-Cuenca, and Jorge Pagán-Ortiz, and José Luis Aguayo-Albasini
January 1973, Akusherstvo i ginekologiia,
Diego de Alcalá Martínez-Gómez, and Cristóbal Ramírez-Almagro, and Alvaro Campillo-Soto, and Germán Morales-Cuenca, and Jorge Pagán-Ortiz, and José Luis Aguayo-Albasini
June 2012, Seminars in vascular surgery,
Diego de Alcalá Martínez-Gómez, and Cristóbal Ramírez-Almagro, and Alvaro Campillo-Soto, and Germán Morales-Cuenca, and Jorge Pagán-Ortiz, and José Luis Aguayo-Albasini
November 1992, Diabetes care,
Diego de Alcalá Martínez-Gómez, and Cristóbal Ramírez-Almagro, and Alvaro Campillo-Soto, and Germán Morales-Cuenca, and Jorge Pagán-Ortiz, and José Luis Aguayo-Albasini
April 2003, Medizinische Klinik (Munich, Germany : 1983),
Diego de Alcalá Martínez-Gómez, and Cristóbal Ramírez-Almagro, and Alvaro Campillo-Soto, and Germán Morales-Cuenca, and Jorge Pagán-Ortiz, and José Luis Aguayo-Albasini
December 1999, FEMS immunology and medical microbiology,
Diego de Alcalá Martínez-Gómez, and Cristóbal Ramírez-Almagro, and Alvaro Campillo-Soto, and Germán Morales-Cuenca, and Jorge Pagán-Ortiz, and José Luis Aguayo-Albasini
December 2005, Nihon rinsho. Japanese journal of clinical medicine,
Diego de Alcalá Martínez-Gómez, and Cristóbal Ramírez-Almagro, and Alvaro Campillo-Soto, and Germán Morales-Cuenca, and Jorge Pagán-Ortiz, and José Luis Aguayo-Albasini
July 2019, Odontology,
Copied contents to your clipboard!